Valion Bio (VBIO) Gross Margin Growth (1y) (2022 - 2026)
Valion Bio (VBIO) Gross Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 1,966.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 228.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -475.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,672.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1,034.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | -17,818.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17,818.00 |
| Dec 31, 2025 | 22,403.00 |
| Sep 30, 2025 | -13,424.00 |
| Jun 30, 2025 | 4,136.00 |
| Mar 31, 2025 | 2,143.00 |
| Dec 31, 2024 | -13,418.00 |
| Sep 30, 2024 | -338.00 |
| Jun 30, 2024 | -1,646.00 |
| Mar 31, 2024 | 1,995.00 |
| Dec 31, 2023 | -914.00 |
| Sep 30, 2023 | 2,509.00 |
| Jun 30, 2023 | 1,421.00 |
| Mar 31, 2023 | 1,370.00 |
| Dec 31, 2022 | 1,105.00 |
| Sep 30, 2022 | 2,259.00 |
| Jun 30, 2022 | 3,599.00 |
| Mar 31, 2022 | 954.00 |